---
title: "Scientists find immune drug that could halt skin cancer’s deadly spread"
date: 2025-10-20T15:14:51.000Z
category: Health
externalLink: "https://www.sciencedaily.com/releases/2025/10/251020092821.htm"
image: ""
excerpt: "Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall weren’t significantly changed, the results hint at a meaningful benefit in preventing cancer spread. The nationwide trial, one of the largest of its kind, underscores the promise of immunotherapy for rare, aggressive cancers.…"
---